Clinical Trial Update: Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial update on safety and efficacy of FolateScan (Technetium Tc 99m EC20) in subjects with pituitary tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pituitary Tumors

Drugs mentioned

• FolateScan

Snippet

Sponsor: Endocyte | Conditions: Pituitary Tumors | Phase 2 | Status: COMPLETED